Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Tianda Pharmaceuticals Ltd. ( (HK:0455) ) is now available.
Tianda Pharmaceuticals Ltd. announced its consolidated financial results for the year ended December 31, 2024, reporting a significant decline in revenue from HK$532,089,000 in 2023 to HK$329,937,000 in 2024. The company experienced a total comprehensive loss of HK$80,686,000, reflecting challenges in sales and increased losses, which may impact its market positioning and stakeholder confidence.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products and services.
YTD Price Performance: 8.24%
Average Trading Volume: 70,130
Technical Sentiment Signal: Buy
Current Market Cap: HK$395.6M
Learn more about 0455 stock on TipRanks’ Stock Analysis page.